Inventor
ZIMMERMANN TRACY
US11 patents
⚠️ This page may combine multiple inventors who share the name “ZIMMERMANN TRACY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
10 patentsUS9796974B2Oct 24, 2017
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC119 citations99
US9399775B2Jul 26, 2016
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
ALNYLAM PHARMACEUTICALS INC51 citations98
US10668170B2Jun 2, 2020
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC22 citations94
US10208307B2Feb 19, 2019
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
ALNYLAM PHARMACEUTICALS INC16 citations93
US11406716B2Aug 9, 2022
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC8 citations86
US10570391B2Feb 25, 2020
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
ALNYLAM PHARMACEUTICALS INC12 citations86
US11286486B2Mar 29, 2022
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
ALNYLAM PHARMACEUTICALS INC8 citations85
US10683501B2Jun 16, 2020
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
ALNYLAM PHARMACEUTICALS INC8 citations83
US12049628B2Jul 30, 2024
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
ALNYLAM PHARMACEUTICALS INC1 citations72
US12290573B2May 6, 2025
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC0 citations62